J. White

发表

A multicentre phase II pilot study of epirubicin and Taxol (paclitaxel) in patients with advanced breast cancer.

J. Carmichael, C. Poole, N. Stuart, 2000, Clinical oncology (Royal College of Radiologists (Great Britain)).

Lymphoma presenting as a parotid tumour: a population-based study of diagnosis, treatment and outcome on behalf of the Scotland and Newcastle Lymphoma Group.

S. Proctor, P. Taylor, P. Arullendran, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK).

B. Angus, G. Jackson, K. Wood, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Successful Use of National Cancer Registry Data to Monitor the Effective Use of Imatinib for Treating Chronic Myeloid Leukaemia

P. Shepherd, M. Drummond, T. Holyoake, 2008, Scottish medical journal.

Primary non-Hodgkins lymphoma of muscle.

A. Lessells, H. Roddie, J. White, 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

lymphoma: a population-based study outcome in age-defined subgroups of patients with classic Hodgkin Impact of tumor Epstein-Barr virus status on presenting features and

F. Alexander, B. Angus, R. Jarrett, 2013 .

Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen

L. Goldstein, W. Fridman, H. Brandwein, 2012, Cancer Immunology, Immunotherapy.

A randomized phase III study comparing paclitaxel-BEP (T-BEP) to standard BEP in patients with in intermediate prognosis germ cell cancer (GCC): An intergroup study of EORTC, German TCSG/AUO, MRC, and Spanish GCC group (EORTC 30983).

L. Collette, P. Albers, J. Witjes, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study.

E. Jaffe, M. Raffeld, M. Turner, 2000, Archives of dermatology.

Extranodal follicular lymphoma: a clinicopathological and genetic analysis of 15 cases arising at non‐cutaneous extranodal sites

P. Batstone, J. Goodlad, J. White, 2004, Histopathology.

BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma

N. Kernohan, D. Levison, P. Batstone, 2006, Histopathology.

Immunocytochemical staining of ovarian cyst aspirates with monoclonal antibody against inhibin

W. McCluggage, N. Anderson, A. Patterson, 1998, Cytopathology : official journal of the British Society for Clinical Cytology.

Point-of-care (POC) diagnostic assay for 5-fluorouracil (5-FU) quantitation to enable dose adjustment and detect dihydropyrimidine dehydrogenase (DPD) deficiency.

M. Bamat, R. V. von Borstel, J. White, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.

A. Hauschild, D. Schadendorf, J. Kirkwood, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.

R. Prescott, D. Cameron, W. Thompson, 1997, European journal of cancer.

Analysis of a National Programme for Selective Internal Radiation Therapy for Colorectal Cancer Liver Metastases.

N. Slevin, T. See, M. Dale, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.

G. Linette, J. Sosman, J. Kirkwood, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.

L. Esserman, C. Denkert, E. Provenzano, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary.

D. Dodwell, K. Horgan, O. Kearins, 2016, Clinical radiology.

A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III).

R. Prescott, B. Angus, G. Jackson, 2002, European journal of cancer.

LOPP chemotherapy as a first‐line treatment for dogs with T‐cell lymphoma

S. Tzannes, V. Langová, S. Nguyen, 2018, Veterinary and comparative oncology.

Referral Rate to Oncologists and its Variation by Hospital for Colorectal Cancer Patients

M. Winget, Y. Yasui, C. Gara, 2012, Annals of Surgical Oncology.

Intermediate filament expression of ductal carcinoma cells in fine needle aspirates of the breast.

P. Maxwell, M. Heatley, A. Patterson, 1997, Acta Cytologica.

Total Registration of Non-Hodgkin's Lymphoma and Hodgkin's Disease in Scotland: Effect of Deprivation and Caseload on Outcome

A. Lessells, A. Rattray, J. White, 2003, Hematology.

Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK).

B. Angus, K. Wood, S. Proctor, 2003, Annals of Oncology.